Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Bizieux · SciRah

Researcher profile · Semantic Scholar

A. Bizieux

Share profile

A. Bizieux — researcher profile on SciRah

h-index: 10
Works: 27
Citations: 295

Most-cited papers

Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients.
A. Vallée, M. Marcq, A. Bizieux, C. El Kouri +4 more
2013Lung Cancer81 citations
Semantic Scholar
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study
Hugues Bourgeois, F. Grudé, P. Solal-Céligny, O. Dupuis +49 more
2017Annals of Oncology49 citations Open access
Semantic Scholar
Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study.
J. Auliac, C. Chouaid, L. Greiller, Isabelle Monnet +12 more
2014Lung Cancer30 citations
Semantic Scholar
Detection of EGFR Mutations in the Plasma of Patients with Lung Adenocarcinoma for Real-Time Monitoring of Therapeutic Response to Tyrosine Kinase Inhibitors?
M. Marcq, A. Vallée, A. Bizieux, M. Denis
2014Journal of Thoracic Oncology22 citations Open access
Semantic Scholar
Survival of Patients with Lung Adenocarcinoma Diagnosed in 2000, 2010, and 2020.
D. Debieuvre, L. Falchero, O. Molinier, S. Couraud +12 more
2025NEJM Evidence19 citations
Semantic Scholar
Impact of Continuing First-Line EGFR Tyrosine Kinase Inhibitor Therapy Beyond RECIST Disease Progression in Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer (NSCLC): Retrospective GFPC 04-13 Study
J. Auliac, Clément Fournier, C. Valette, M. Pérol +14 more
2016Targeted oncology19 citations
Semantic Scholar
Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination for stage-IV non-small-cell lung cancer - VinMetAtezo trial, (GFPC‡ 04-2017).
A. Vergnenègre, I. Monnet, A. Bizieux, M. Bernardi +4 more
2020Future Oncology15 citations Open access
Semantic Scholar
Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo).
A. Vergnenègre, I. Monnet, C. Ricordel, A. Bizieux +11 more
2023Lung Cancer12 citations
Semantic Scholar
Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02–14 Study)
J. Auliac, I. Monnet, C. Dubos-Arvis, A. Chiappa +8 more
2017Targeted oncology12 citations
Semantic Scholar
Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis
K. Amrane, B. Cabarrou, G. Justeau, S. Schneider +16 more
2025ESMO Open10 citations
Semantic Scholar
Mid-term pulmonary sequelae after hospitalisation for COVID-19: The French SISCOVID cohort
G. Calcaianu, Samuel Degoul, B. Michau, Thibault Payen +17 more
2022Respiratory medical research8 citations Open access
Semantic Scholar
Association between obstructive sleep apnoea and liver fibrosis in patients with suspected nonalcoholic fatty liver disease.
W. Trzepizur, Jérôme Boursier, Jérémie Poilane, Christophe Bureau +9 more
2025Sleep7 citations
Semantic Scholar
Multicenter phase II trial of nintedanib plus docetaxel in second-line treatment in advanced non-squamous non-small cell lung cancer patients refractory to first-line platin-based chemotherapy (REFRACT GFPC 02-15 study).
J. Auliac, I. Monnet, A. Bizieux, L. Greillier +8 more
2021Lung Cancer4 citations
Semantic Scholar
Absolute Quantification of Nucleotide Variants in Cell-Free DNA via Quantitative NGS: Clinical Application in Non-Small Cell Lung Cancer Patients
G. Herbreteau, M. Marcq, C. Sauzay, Maxime Carpentier +7 more
2025Cancers2 citations Open access
Semantic Scholar
Impact of Programmed Death Ligand 1 Expression in Advanced Non-Small–Cell Lung Cancer Patients, Treated by Chemotherapy (GFPC 06-2015 Study)
J. Auliac, F. Guisier, A. Bizieux, P. Assouline +6 more
2020OncoTargets and Therapy2 citations Open access
Semantic Scholar
A prospective analysis of the management practices for patients with Stage-III-N2Non-Small-Cell lung cancer (OBSERVE IIIA-B GFPC 04-2020Study).
Mathilde Jacob, P. Fournel, C. Tissot, J. Cadranel +27 more
2024Lung Cancer1 citations Open access
Semantic Scholar
P2.01-09 VinMetAtezo: Phase II Trial of Metronomic Oral Vinorelbine with Atezolizumab for Recurrent Stage IV NSCLC (GFPC*04-08)
A. Vergnenègre, G. Robinet, C. Chouaid, A. Bizieux +2 more
2019Journal of Thoracic Oncology1 citations Open access
Semantic Scholar
Corrigendum to “Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study” [Lung Cancer 85 (2014) 415–419]
J. Auliac, C. Chouaid, L. Greillier, I. Monnet +12 more
20151 citations
Semantic Scholar
Second-line chemotherapy efficacy is not affected by prior exposure to immunotherapy in extensive-disease small-cell lung cancer: results from the ESME French national real-world cohort
E. Gobbini, M. H. Diallo, C. Clément-Duchêne, C. Chouaid +12 more
2026ESMO Open0 citations Open access
Semantic Scholar
1906P Impact of smoking status on the efficacy of first-line immune checkpoint inhibitors in stage IV oncogene-addicted lung cancer
E. Volant, E. Martin, G. Justeau, C. Clément-Duchêne +16 more
2025Annals of Oncology0 citations Open access
Semantic Scholar
EP12.64 Real-World Effectiveness of First-Line Osimertinib in EGFR-Mutated NSCLC: Interim Results From the French POSITHES Study
J-B. Aulia, A. Bizieux, O. Bylicki, F. Guisier +7 more
2025Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
Association of sleep-related hypoxia with survival in patients with non-small cell lung cancer – the NEOSAS-GFPC study group
G. Justeau, L. Greillier, F. Viñas, L. Falchero +14 more
2024Lung Cancer0 citations
Semantic Scholar
1310P VinMetAtezo: Phase II trial of metronomic oral vinorelbine (MOV) with atezolizumab (ATZ) for recurrent stage IV NSCLC (GFPC*04-18)**
A. Vergnenègre, I. Monnet, C. Ricordel, A. Bizieux +10 more
20200 citations Open access
Semantic Scholar
1326P Liver metastasis but not bone metastasis impact overall survival of advanced non-small cell lung cancer (NSCLC) treated by nivolumab (GFPC 04-2016)
C. Decroisette, F. Guisier, O. Bylicki, R. Lamy +13 more
20200 citations Open access
Semantic Scholar
MA14.06 Nintedanib-Docetaxel in 2nd Line Treatment in No Squamous Non-Small Cell Lung Cancer Patients, Refractory to First Line Treatment (GFPC02-15)
J. Auliac, I. Monnet, A. Bizieux, L. Greillier +8 more
2019Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
250PEGFR TESTING FROM CIRCULATING CELL-FREE DNA: READY FOR ROUTINE PRACTICE.
M. Denis, A. Vallée, C. El Kouri, H. Lacroix +4 more
2014Annals of Oncology0 citations Open access
Semantic Scholar
1287PRETROSPECTIVE MULTICENTER STUDY IN NON SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) ACTIVATING MUTATION TREATED FIRST-LINE TYROSINE KINASE INHIBITOR (TKI): EVALUATION OF PROGRESSION ACCORDING TO RECIST, THERAPEUTIC APPROACH AND ITS EFFECT.
J. Auliac, Clément Fournier, C. Valette, M. Pérol +14 more
2014Annals of Oncology0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Vergnenègre×12
Invite
A. Vergnenègre — researcher profile on SciRah
L. Falchero×10
Invite
L. Falchero — researcher profile on SciRah
J. Auliac×9
Invite
J. Auliac — researcher profile on SciRah
R. Lamy×8
Invite
R. Lamy — researcher profile on SciRah

×8

Invite

I. Monnet — researcher profile on SciRah

D. Debieuvre×6

Invite

D. Debieuvre — researcher profile on SciRah

Invite

G. Robinet — researcher profile on SciRah

Invite

F. Guisier — researcher profile on SciRah

Invite

G. Justeau — researcher profile on SciRah

L. Greillier×6

Invite

L. Greillier — researcher profile on SciRah

Invite

R. Corre — researcher profile on SciRah

Invite

P. Fournel — researcher profile on SciRah